Biomarkers are Significant Clinical Features in Obsessive-Compulsive Disorder

Authors

  • Amir Hossein Mohammadi Research Center for Biochemistry and Nutrition in Metabolic Diseases, Institute for Basic Sciences, Kashan University of Medical Sciences, Kashan – Iran https://orcid.org/0000-0003-4157-3588

DOI:

https://doi.org/10.48112/bcs.v2i2.349

Abstract

Abstract Views: 138

Letter to American Psychiatric Association

Keywords:

Biomarkers, Clinical Features, Obsessive-Compulsive Disorder

Metrics

Metrics Loading ...

References

Abramovitch, A., McCormack, B., Brunner, D., Johnson, M., & Wofford, N. (2019). The impact of symptom severity on cognitive function in obsessive-compulsive disorder: A meta-analysis. Clinical psychology review, 67, 36-44. https://doi.org/10.1016/j.cpr.2018.09.003

American Psychiatric Association, D., & American Psychiatric Association. (2013). Diagnostic and statistical manual of mental disorders: DSM-5 (Vol. 5, No. 5). Washington, DC: American psychiatric association.

Balandeh, E., Karimian, M., Behjati, M., & Mohammadi, A. H. (2021). Serum vitamins and homocysteine levels in obsessive-compulsive disorder: a systematic review and meta-analysis. Neuropsychobiology, 80(6), 502-515. https://doi.org/10.1159/000514075

Bey, K., Campos-Martin, R., Klawohn, J., Reuter, B., Grützmann, R., Riesel, A., ... & Kathmann, N. (2022). Hypermethylation of the oxytocin receptor gene (OXTR) in obsessive-compulsive disorder: Further evidence for a biomarker of disease and treatment response. Epigenetics, 17(6), 642-652. https://doi.org/10.1080/15592294.2021.1943864

Bijl, R. V., Ravelli, A., & van ZESSEN, G. (1998). Prevalence of psychiatric disorder in the general population: results of The Netherlands Mental Health Survey and Incidence Study (NEMESIS). Social psychiatry and psychiatric epidemiology, 33, 587-595. https://doi.org/10.1007/s001270050098

Bobes, J., González, M. P., Bascaran, M. T., Arango, C., Saiz, P. A., & Bousono, M. (2001). Quality of life and disability in patients with obsessive-compulsive disorder. European psychiatry, 16(4), 239-245. https://doi.org/10.1016/S0924-9338(01)00571-5

Cosco, T. D., Pillinger, T., Emam, H., Solmi, M., Budhdeo, S., Matthew Prina, A., ... & Carvalho, A. F. (2019). Immune aberrations in obsessive-compulsive disorder: a systematic review and meta-analysis. Molecular neurobiology, 56, 4751-4759. https://doi.org/10.1007/s12035-018-1409-x

Endres, D., Pollak, T. A., Bechter, K., Denzel, D., Pitsch, K., Nickel, K., ... & Schiele, M. A. (2022). Immunological causes of obsessive-compulsive disorder: is it time for the concept of an “autoimmune OCD” subtype?. Translational psychiatry, 12(1), 5. https://doi.org/10.1038/s41398-021-01700-4

Gray, S. M., & Bloch, M. H. (2012). Systematic review of proinflammatory cytokines in obsessive-compulsive disorder. Current psychiatry reports, 14, 220-228. https://doi.org/10.1007/s11920-012-0272-0

Hao, L. S., Du, Y., Chen, L., Jiao, Y. G., & Cheng, Y. (2022). Brain-derived neurotrophic factor as a biomarker for obsessive-compulsive disorder: A meta-analysis. Journal of Psychiatric Research. https://doi.org/10.1016/j.jpsychires.2022.05.026

Hollander, E. (1998). Treatment of obsessive-compulsive spectrum disorders with SSRIs. The British Journal of Psychiatry, 173(S35), 7-12. https://doi.org/10.1192/S0007125000297845

Maia, A., Oliveira, J., Lajnef, M., Mallet, L., Tamouza, R., Leboyer, M., & Oliveira‐Maia, A. J. (2019). Oxidative and nitrosative stress markers in obsessive–compulsive disorder: a systematic review and meta‐analysis. Acta Psychiatrica Scandinavica, 139(5), 420-433. https://doi.org/10.1111/acps.13026

Mohammadi, A. H., Balandeh, E., & Milajerdi, A. (2021). Malondialdehyde concentrations in obsessive–compulsive disorder: a systematic review and meta-analysis. Annals of general psychiatry, 20(1), 34. https://doi.org/10.1186/s12991-021-00354-2

Mohammadi, A. H., Balandeh, E., Hasani, J., Karimian, M., Pourfarzam, M., Bahmani, F., & Namazi, G. (2021). The Oxidative Status and Na+/K+-ATPase Activity in Obsessive-Compulsive Disorder: A Case Control Study.

Piras, F., Piras, F., Caltagirone, C., & Spalletta, G. (2013). Brain circuitries of obsessive compulsive disorder: a systematic review and meta-analysis of diffusion tensor imaging studies. Neuroscience & Biobehavioral Reviews, 37(10), 2856-2877. https://doi.org/10.1016/j.neubiorev.2013.10.008

Renna, M. E., O'Toole, M. S., Spaeth, P. E., Lekander, M., & Mennin, D. S. (2018). The association between anxiety, traumatic stress, and obsessive–compulsive disorders and chronic inflammation: A systematic review and meta‐analysis. Depression and anxiety, 35(11), 1081-1094. https://doi.org/10.1002/da.22790

Rotge, J. Y., Guehl, D., Dilharreguy, B., Tignol, J., Bioulac, B., Allard, M., ... & Aouizerate, B. (2009). Meta-analysis of brain volume changes in obsessive-compulsive disorder. Biological psychiatry, 65(1), 75-83. https://doi.org/10.1016/j.biopsych.2008.06.019

Ruscio, A. M., Stein, D. J., Chiu, W. T., & Kessler, R. C. (2010). The epidemiology of obsessive-compulsive disorder in the National Comorbidity Survey Replication. Molecular psychiatry, 15(1), 53-63. https://doi.org/10.1038/mp.2008.94

Sina, M., Ahmadiani, A., Asadi, S., & Shams, J. (2018). Association of serotonin receptor 2a haplotypes with obsessive–compulsive disorder and its treatment response in iranian patients: a genetic and pharmacogenetic study. Neuropsychiatric Disease and Treatment, 1199-1209.

Sousa-Lima, J., Moreira, P. S., Raposo-Lima, C., Sousa, N., & Morgado, P. (2019). Relationship between obsessive compulsive disorder and cortisol: Systematic review and meta-analysis. European Neuropsychopharmacology, 29(11), 1185-1198. https://doi.org/10.1016/j.euroneuro.2019.09.001

Stein, D. J., Costa, D. L., Lochner, C., Miguel, E. C., Reddy, Y. J., Shavitt, R. G., ... & Simpson, H. B. (2019). Obsessive–compulsive disorder. Nature reviews Disease primers, 5(1), 52. https://doi.org/10.1038/s41572-019-0102-3

Stein, D. J., Roberts, M., Hollander, E., Rowland, C., & Serebro, P. (1996). Quality of life and pharmaco-economic aspects of obsessive-compulsive disorder. A South African survey. South African medical journal= Suid-Afrikaanse tydskrif vir geneeskunde, 86(12 Suppl), 1579-1582.

Taylor, S. (2016). Disorder‐specific genetic factors in obsessive‐compulsive disorder: A comprehensive meta‐analysis. American journal of medical genetics part B: neuropsychiatric genetics, 171(3), 325-332. https://doi.org/10.1002/ajmg.b.32407

Yan, S., Liu, H., Yu, Y., Han, N., & Du, W. (2022). Changes of Serum Homocysteine and Vitamin B12, but Not Folate Are Correlated With Obsessive-Compulsive Disorder: A Systematic Review and Meta-Analysis of Case-Control Studies. Frontiers in Psychiatry, 13.

Zai, G., Zai, C. C., Arnold, P. D., Freeman, N., Burroughs, E., Kennedy, J. L., & Richter, M. A. (2015). Meta-analysis and association of brain-derived neurotrophic factor (BDNF) gene with obsessive-compulsive disorder. Psychiatric genetics, 25(2), 95-96. https://doi.org/10.1097/ypg.0000000000000077

Published

2023-04-01

How to Cite

Mohammadi, A. H. (2023). Biomarkers are Significant Clinical Features in Obsessive-Compulsive Disorder. Biomedicine and Chemical Sciences, 2(2), 163–165. https://doi.org/10.48112/bcs.v2i2.349

Issue

Section

Letters